Salt and crystal form of egfr inhibitor, and composition and use thereof
US-2024352053-A1 · Oct 24, 2024 · US
Triptolide prodrugs
US9150600B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9150600-B2 |
| Application number | US-201313938971-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2013 |
| Priority date | May 7, 2009 |
| Publication date | Oct 6, 2015 |
| Grant date | Oct 6, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention provides compounds of formula I: or a salt thereof. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods using the compounds of formula I.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating cancer in a mammal, comprising administering to the mammal a compound of formula I: wherein: each R 1 is independently H, (C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkyl-, (C 3 -C 6 )cycloalkyl or aryl; and each R 2 is independently H, (C 1 -C 6 )alkyl, aryl(C 1 -C 6 )alkyl-, (C 3 -C 6 )cycloalkyl or aryl; or R 1 and R 2 together w…
Assignees
Inventors
Classifications
- C07F9/6561Primary
Chemistry & Metallurgy · mapped topic
- A61K31/665Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9150600B2 cover?
- The invention provides compounds of formula I: or a salt thereof. The invention also provides pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods using the compounds of formula I.
- Who is the assignee on this patent?
- Univ Minnesota
- What technology area does this patent fall under?
- Primary CPC classification C07F9/6561. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).